This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Azab MB, Pejovic MH, Theodore C et al. (1988) Prognostic factors in gestational trophoblastic tumors: a multivariate analysis. Cancer 62: 585–592
Bagshawe KD, Dent J, Webb J (1986) Hydatidiform mole in England and Wales 1973–83. Lancet 2:673–677
Berkowitz RS, Goldstein DP (1995) Gestational trophoblast disease. Cancer 76:2079–2085
Berkowitz RS, Goldstein DP (1996) Chorionic tumors. New Engl J Med 335: 1740–1748
Berkowitz RS, Goldstein DP, Bernstein MR (1986) Ten year’s experience with methotrexate and folinic acid as primary therapy for gestational trophoblastic disease. Gynecol Oncol 23:111–118
Chen Q, Stone PR, McCowan LM, Chamley LW (2005) Interaction of Jar choriocarcinoma cells with endothelial cell monolayers. Placenta 26: 617–625
Flam F, Lundstrom V, Petterson F (1991) Medical induction prior to surgical evacuation of hydatidiform mole: Is there a greater risk of persistent trophoblastic disease? Eur J Obstet Gynecol Reprod Biol 42:57–60
Goldstein DP, Berkowitz RS (1995) Prophylactic chemotherapy of complete molar pregnancy. Semin Oncol 22:157–160
Hancock BW, Welch EM, Gillespie AM, Newlands ES (2000) A retrospective comparison of current and proposed staging and scoring systems for persistent gestational trophoblastic disease. Int J Gynecol Cancer 10: 318–322
Homesley HD (1994) Development of single-agent regimens for gestational trophoblastic disease. J Reprod Med 39:185–192
Homesley HD, Blessing JA, Rettenmaier M, Capizzi RL, Major FJ, Twiggs LB (1988) Weekly intramuscular methotrexate for nonmetastatic gestational trophoblast disease. Obstet Gynecol 72:413–418
Jauniaux E, Brown R, Snijders RJ, Noble P, Nicolaides KH (1997) Early prenatal diagnosis of triploidy. Am J Obstet Gynecol 176:550–554
Kendall A, Gillmore R, Newlands E (2002) Chemotherapy for trophoblastic disease: current standards. Curr Opin Obstet Gynecol 14:33–38
Kim DS, Moon H, Kim KT, Moon YJ, Hwang YY (1986) Effects of prophylactic chemotherapy for persistent trophoblastic disease in patients with complete hydatidiform mole. Obstet Gynecol 67:690–694
Kohorn EI, Goldstein DP, Hancock BW, Kim SJ, Lurain JR, Newlands E, Soper JT, Wong LC, Workshop Report (2000) Combining the staging system of the International Federation of Gynecology and Obstetrics with the scoring system of the World Heath Organization for Trophoblastic Neoplasia. Report of the Working Committee of the International Society for the Study of Trophoblastic Disease and the International Gynecologic Cancer Society. Int J Gynecol Cancer 10:84–88
Loret de Mola JR, Goldfarb JM (1995) Reproductive performance of patients after gestational trophoblastic disease. Semin Oncol 22: 193–197
Lurain JR, Casanova LA, Miller DS, Rademaker AW (1991) Prognostic factors in gestational trophoblastic tumors: A proposed new scoring system based on mulitvariate analysis. Am J Obstet Gynecol 164:611–616
Redline RW, Abdul-Karim FW (1995) Pathology of gestational trophoblastic disease. Semin Oncol 22:96–109
Sebire NJ, Rees H, Paradinas F, Seckl M, Newlands E (2001) The diagnostic implications of routine ultrasound examination in histologically confirmed early molar pregnancies. Ultrasound Obstet Gynecol 18:662–665
Soper JT (1995) Identification and management of high-risk gestational trophoblastic disease. Semin Oncol 22:172–84.
Soper JT, Clarke-Pearson D, Hammond CB (1988) Metastatic gestational trophoblastic disease: prognostic factors in previously untreated patients. Obstet Gynecol 71:338–343
Soper JT, Clarke-Pearson DL, Berchuck A, Rodriguez G, Hammond CB (1994) 5-Day methotrexate for women with metastatic gestational trophoblastic disease. Gynecol Oncol 54:76–79
Soto-Wright V, Bernstein M, Goldstein DP, Berkowitz RS (1995)The changing clinical presentation of complete molar pregnancy. Obstet Gynecol 86:775–779
Spencer K, Liao AW, Skentou H, Cicero S, Nicolaides KH (2000) Screening for triploidy by fetal nuchal translucency and maternal serum free beta-HCG and PAPP-A at 10–14 weeks of gestation. Prenat Diagn 20: 495–499
Steigrad SJ (2003) Epidemiology of gestational trophoblastic diseases. Best Pract Res Clin Obstet Gynaecol 17:837–847
Vaisbuch E, Ben-Arie A, Dgani R, Perlman S, Sokolovsky N, Hagay Z (2005) Twin pregnancy consisting of a complete hydatidiform mole and coexistent fetus: report of two cases and review of literature. Gynecol Oncol 98:19–23
Wolf NG, Lage JM (1995) Genetic analysis of gestational trophoblastic disease: a review. Semin Oncol 22:113–120
WHO Scientific Group (1983) Gestational trophoblastic disease. WHO Tech Rep Ser 692
Yedema KA, Verheijen RH, Kenemans P, Schijf CP, Borm GF, Segers MF, Thomas CM (1993) Identification of patients with persistent trophoblastic disease by means of a normal human chorionic gonadotropin regression curve. Am J Obstet Gynecol 168:787–792
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer Medizin Verlag Heidelberg
About this chapter
Cite this chapter
Krampl, E., Strohmer, H. (2006). Trophoblasterkrankungen. In: Schneider, H., Husslein, P., Schneider, KT.M. (eds) Die Geburtshilfe. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-33897-0_4
Download citation
DOI: https://doi.org/10.1007/978-3-540-33897-0_4
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-33896-3
Online ISBN: 978-3-540-33897-0
eBook Packages: Medicine (German Language)